Brief: Tela Bio Posts Quarterly Loss Per Share Of $0.57
Nov 10 (Reuters) - TELA Bio Inc TELA.O :
* TELA BIO REPORTS STRONG THIRD QUARTER 2021 REVENUES
REFLECTING
CONTINUED GROWTH DRIVEN BY INCREASED DEMAND
* Q3 REVENUE ROSE 44 PERCENT TO $7.7 MILLION
* MAINTAINING EXPECTATION FOR FY REVENUE TO BE IN RANGE OF
$28.0
MILLION TO $30.0 MILLION
* QTRLY LOSS PER SHARE $0.57
Source text for Eikon: ID:nGNX1LrB9f
Further company coverage: TELA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants